Investor Update

Invitation to Roche’s virtual event on key oncology data presented at ASCO 2020




 

We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Friday, 29 May 2020, highlighting Roche data accepted for presentation via the ASCO20 Virtual Scientific Program May 29-31 2020.

17:00 – 18:15 CEST / 16:00 - 17:15 BST
11:00 – 12:15 am EDT / 8:00 - 9:15 am PDT


Audio webcast and conference call will start with a presentation, followed by a Q&A session (live access to the speakers).

Access to audio webcast and conference call
Dial in details will soon follow.

A replay of the webcast will be available via > ir.roche.com


 

Best regards,

Karl Mahler
Head of Investor Relations and Roche Group Planning
 


Sabine Borngräber
Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com
 
Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com